Aggregator
‘In the City’ recap: Amanda admits to beta blocker use at ‘Summer House’ reunion, Lindsay confronts Whitney
‘In the City’ recap: Amanda admits to beta blocker use at ‘Summer House’ reunion, Lindsay confronts Whitney
Paulina Porizkova says this serum works wonders for ‘dry, mature skin,’ and it’s 33% off at Nordstrom
Paulina Porizkova says this serum works wonders for ‘dry, mature skin,’ and it’s 33% off at Nordstrom
‘RHONY’ star Sai De Silva spills the tea on season 16, new cast members and her divorce
‘RHONY’ star Sai De Silva spills the tea on season 16, new cast members and her divorce
Cruise ship crewmember found dead in her cabin by her partner: reports
Nolan Wells’ preliminary autopsy results released after teen vanished on Fourth of July trip — sparking even more questions
Can Justin Wrobleski force his way into Dodgers’ playoff rotation?
Djimon Hounsou’s movie paydays exposed in custody battle after claiming he’s ‘struggling to make a living’
Djimon Hounsou’s movie paydays exposed in custody battle after claiming he’s ‘struggling to make a living’
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US.
"This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote on Truth Social late Tuesday.
He continued, "The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is," adding, "Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America."
Trump's announcement is the latest effort to reshore critical supply chains, and in this case, boost domestic production of generic drugs. Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries. At least 90% of medicines sold in the U.S. are generics.
UBS analyst Aditi Samajpati told clients earlier that Trump's move to reshore generic drug production puts Indian pharmaceutical companies "on notice."
Samajpati said:
President Donald Trump has threatened steep tariffs on generic-drug imports to push manufacturing back to the US, though his plan includes a two-year tariff-free window before levies rise to 100% from August 2028 and 200% from August 2029. India is highly exposed: its generic medicines account for nearly 40% of US generic-drug volume, used widely to treat hypertension, diabetes, cancer, and infectious diseases.
In FY2024-25, India's pharma exports to the US totalled $9.7bn, according to the Global Trade Research Initiative. Yet implementation is uncertain given prior unfulfilled tariff threats, a February bilateral trade pact that included negotiated outcomes for generics, and India's 30%-50% manufacturing-cost advantage. The risk of immediate disruption is limited as investors assess whether policy pressure can realistically shift low-cost supply chains back to the US, especially if execution stretches beyond Trump's term.
Goldman analyst Matt Dellatorre offered clients a way to profit from this announcement:
For our generics coverage, we view the group as relatively well-positioned given: AMRX (significant US infrastructure), TEVA (diversified manufacturing; branded portfolio), and VTRS (diversified manufacturing; limited US exposure).
The national security case for reshoring critical generic-drug supply chains stems directly from Covid-era disruptions of essential medicines, active pharmaceutical ingredients, protective equipment, and medical devices. Years of offshoring have left the US dangerously dependent on foreign production, such as that in India.
In the event of a future supply shock, particularly one triggered by conflict in the Pacific, Washington could be confronted with shortages far more severe than the Covid-era. Rebuilding domestic production would give the US greater resilience to absorb any future supply shock without jeopardizing access to critical medical supplies.
Tyler Durden Wed, 07/22/2026 - 09:45Christopher Nolan completely defeated attempts to cancel ‘The Odyssey’ — we reveal the elite group too big to boycott
Five drown in Ohio river rescue, Trump admin freezes $1B in medicaid funding
‘Devastated’ Millie Bobby Brown reacts to ‘Godzilla vs Kong’ co-star Kaylee Hottle’s tragic death at 18
‘Devastated’ Millie Bobby Brown reacts to ‘Godzilla vs Kong’ co-star Kaylee Hottle’s tragic death at 18
Chilling New Clues Challenge Suicide Claim In Los Alamos Lab Worker's Death
Authored by Steve Watson via Modernity News,
Fresh evidence recovered from the remote New Mexico forest where Los Alamos National Laboratory administrative assistant Melissa Casias was found has blown major holes in the suicide narrative.
An independent team hired by her own family discovered bones, torn and bloody clothing, orange peels, strands of what appears to be horse hair, shredded paper that may contain her handwriting, and a tobacco pouch - none of which New Mexico State Police recovered after clearing the scene.
Casias, 53, vanished from her Ranchos de Taos home on June 26, 2025. She left without her purse, keys or wallet. Surveillance captured her walking alone eastward on State Road 518 around 2:20 p.m.
Both her work and personal phones were found at the house, factory-reset and wiped of all data. A blood drop was also discovered inside the residence. Nearly eleven months later, on May 28, 2026, a hiker located her skeletal remains in the McGaffey Ridge area of Carson National Forest next to a handgun her family says did not belong to her.
Initial CT scans showed no gunshot wound and no projectile in the skull. No casing was recovered at the scene. The remote location is difficult to reach on foot, requiring multiple rest stops and water.
Now, new details have raised further serious questions.
Family attorney David Adams of Parnall and Adams Law said an independent search conducted in late June - after police had already cleared the area - turned up the additional items. "The family really wasn't expecting to find any additional information... it certainly turned out to be something much, much more," Adams stated.
He noted the presence of possible horse hair and the rugged terrain: "In my mind, when you see that, you kind of go, okay, well, I could see that you would need a horse to get her up there if you were moving a body, for instance, because how you would otherwise do that."
Melissa Casias, missing for years, was found dead in a New Mexico forest, with her family uncovering shocking new evidence that upends the initial investigation. Law&Crime's Jesse Weber @jessecordweber reports. pic.twitter.com/WFN4UT0Viq
— Law&Crime Network (@LawCrimeNetwork) July 1, 2026Adams also questioned the tobacco pouch, pointing out Casias did not use tobacco, and raised chain-of-custody concerns: "There becomes a question of a chain of custody... Could law enforcement have spat a tobacco pouch in the crime scene? I mean, certainly possible. I mean, that would be an example of just poor training."
The family has rejected claims that Casias intended to disappear or end her life. Earlier reporting revealed she left home with her toothbrush and thyroid medication - items one investigator described as "things that might indicate you're planning to stay alive."
Adams said the family hired his firm after spotting multiple red flags. The new evidence has been turned over to authorities.
The official cause of death remains pending from the Office of the Medical Investigator nearly two months after the remains were identified. The FBI, ordered to examine possible links to other cases, has had no contact with the family according to Adams.
Former FBI agent Ben Hansen assessed the Casias case as roughly "80 percent foul play" and floated the possibility of directed-energy weapons or voice-to-skull technology that could influence behavior without leaving conventional ballistics.
Casias is one of several New Mexico individuals connected to nuclear facilities who disappeared under similar circumstances.
Her case sits inside a larger cluster that first drew national attention when retired Air Force Maj. Gen. William Neil McCasland - widely described as a UFO "gatekeeper" with oversight of top-secret space weapons and advanced aerospace programs - vanished from his Albuquerque home on February 27, 2026, just days after President Trump ordered full disclosure of all UFO and UAP records.
Subsequent cases included a NASA nuclear propulsion expert found charred inside a crashed Tesla.
A NASA-linked aerospace engineer and his family killed in a plane crash.
The death of anti-gravity researcher Amy Eskridge (who had reported directed-energy harassment).
The disappearance of JPL rocket scientist Monica Reza.
And additional personnel tied to nuclear components, rocket alloys and classified aerospace work, including the vanishing of Steven Garcia, a nuclear contractor with top clearance.
By mid-April 2026 the documented total had reached at least eleven. Former FBI Assistant Director Chris Swecker previously noted that administrative staff in high-clearance labs "would basically be in the know on what's going on" and that it "wouldn't be the first time their administrative assistant has been targeted."
Two major sets of previously classified UFO/UAP disclosure files have since been released under the Trump administration. President Trump has publicly addressed the string of cases, stating there is "not much of a connection" and describing many as individual matters while pledging a full report.
NOW – Trump says string of missing and dead scientists are not connected: "There's not much of a connection." pic.twitter.com/BSaOPYDOuo
— Disclose.tv (@disclosetv) April 30, 2026The latest reporting on the missed evidence at the Casias scene only deepens the questions surrounding both her death and the wider pattern. Officials continue to treat each incident in isolation. Families and independent investigators keep finding anomalies that do not fit the tidy explanations being offered.
America's nuclear and advanced-technology workforce is not disposable. When personnel with access to the most sensitive programs keep vanishing or turning up dead under irregular circumstances - especially amid long-overdue transparency on related technologies - the public has every right to demand answers that match the seriousness of the losses.
Your support is crucial in helping us defeat mass censorship. Please consider donating via Locals or check out our unique merch. Follow us on X @ModernityNews.
Tyler Durden Wed, 07/22/2026 - 08:45